99 related articles for article (PubMed ID: 3456405)
1. Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis.
Goldstein CS; Garrick RE; Polin RA; Gerdes JS; Kolski GB; Neilson EG; Douglas SD
J Leukoc Biol; 1986 Apr; 39(4):457-64. PubMed ID: 3456405
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
Davies SJ; Yewdall VM; Ogg CS; Cameron JS
Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
[TBL] [Abstract][Full Text] [Related]
3. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Clin Immunol Immunopathol; 1990 Aug; 56(2):151-8. PubMed ID: 2379325
[TBL] [Abstract][Full Text] [Related]
4. Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD).
Moughal NA; McGregor SJ; Brock JH; Briggs JD; Junor BJ
Eur J Clin Invest; 1991 Dec; 21(6):592-6. PubMed ID: 1778220
[TBL] [Abstract][Full Text] [Related]
5. Changes in the expression of adhesion molecules as peripheral blood monocytes differentiate into peritoneal macrophages.
Faull RJ; Wang J; Stavros W
Nephrol Dial Transplant; 1996 Oct; 11(10):2037-44. PubMed ID: 8918719
[TBL] [Abstract][Full Text] [Related]
6. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis.
Hart PH; Jones CA; Jones KL; Finlay-Jones JJ
Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production.
Zemel D; Koomen GC; Struijk DG; Krediet RT
Blood Purif; 1993; 11(6):378-83. PubMed ID: 8043259
[TBL] [Abstract][Full Text] [Related]
8. Immunologic patterns in CAPD patients with peritonitis.
Lamperi S; Carozzi S
Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
[TBL] [Abstract][Full Text] [Related]
9. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
Lamperi S; Carozzi S
Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta.
Fieren MW; van den Bemd GJ; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
[TBL] [Abstract][Full Text] [Related]
14. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
[TBL] [Abstract][Full Text] [Related]
16. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
[TBL] [Abstract][Full Text] [Related]
17. Immunological defenses in CAPD.
Lamperi S; Carozzi S
Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
[TBL] [Abstract][Full Text] [Related]
18. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Fieren MW; Van den Bemd GJ; Bonta IL
Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
Davenport A; Fernando RL; Varghese Z
Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
